Company intelligence / Profile preview

OVETECH

Tel Aviv, Israel

Ownership: Private
Development stage: Other

Overview

OveTech is a medical technology company specializing in reproductive health and fertility monitoring. The company developed a proprietary saliva-based ovulation detection device designed to provide women with a non-invasive and reusable method for tracking their fertile window. By analyzing the crystallization patterns of saliva (the "ferning" effect) which occur due to hormonal changes, the device offers an alternative to traditional urine-based luteinizing hormone (LH) tests. OveTech's primary focus is on empowering individuals with accessible tools for family planning and fertility management.

Therapeutic areas: Women's Health
Modalities: DeviceDiagnostic
Industry: Physiological Monitoring

Beyond the preview

Go deeper on OVETECH.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OVETECH.

Explore the full profile